title: Anti-hepcidin therapy for iron-restricted anemias.
abstract: In this issue of Blood, Cooke et al demonstrate the potential of a fully human anti-hepcidin antibody as a novel therapeutic for iron-restricted anemias such as anemia of inflammation, cancer, or chronic kidney disease (formerly known as “anemia of chronic diseases”).
authors.affiliation: UNIVERSITY OF CALIFORNIA, LOS ANGELES.
authors.forename: Elizabeta
authors.initials: E
authors.lastname: Nemeth
mesh_terms: D018798:Anemia, Iron-Deficiency / Q000188:drug therapy*; D000818:Animals; D057134:Antibodies, Neutralizing / Q000494:pharmacology*; D004912:Erythrocytes / Q000187:drug effects*; D005260:Female; D006454:Hemoglobins / Q000096:biosynthesis*; D006801:Humans; D007501:Iron / Q000097:blood*; D008297:Male
chemical_list: D057134:Antibodies, Neutralizing; D006454:Hemoglobins; D007501:Iron